Cathy Sue Cutler, who has served as director of the Medical Isotope Research and Production (MIRP) program at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory since 2015, has been tapped to lead a newly created Isotope Research and Production (IP) Department at the Laboratory.
Tag: Medical Isotopes
Faster, safer target prep
Oak Ridge National Laboratory researchers have developed a method to simplify one step of radioisotope production — and it’s faster and safer.
Promising Medical Isotope Made and Processed at Brookhaven Lab
Thanks to a recent upgrade to the medical isotope facilities at Brookhaven National Laboratory, actinium-225 (Ac-225), an isotope that shows great promise for treating cancer, can now be produced, purified, and shipped ready for use directly from the Lab. The first shipment left Brookhaven in mid-March.
The Goldilocks of radioisotopes, just right for treating cancer
There’s a powerful new tool to reduce the harm cancer inflicts: actinium-225, which can be attached to molecules to target cancer in the human body. Tested in worldwide clinical trials against advanced metastatic prostate cancer, the radioisotope has proven effective in eliminating cancers.
Toward Scaling Up Nanocages to Trap Noble Gases
Commercially available materials may be a potentially scalable platform for trapping gases for nuclear energy and other applications.
Department of Energy Announces $4 Million for Isotope R&D
Today, the U.S. Department of Energy (DOE) announced $4 million in funding for 10 awards across 5 efforts to advance R&D for isotope production. This funding is part of a key federal program that produces critical isotopes otherwise unavailable or in short supply for U.S. science, medicine, and industry.
Department of Energy to Provide $2 Million for Studies to Accelerate the Evaluation of Novel, Medically Relevant Isotopes for Use in Pre-clinical and Clinical Medical Trials
The U.S. Department of Energy (DOE) announced up to $2 million in new funding to support translational research and development (R&D) of novel, medically relevant isotopes to accelerate evaluation for usage in pre-clinical and clinical trials.
Caroline Nesaraja: Providing nothing but the best nuclear data
Nuclear physicist Caroline Nesaraja of the Department of Energy’s Oak Ridge National Laboratory evaluates nuclear data. Her work ensures that the scientific community has the best nuclear data for fundamental research and applications including medical isotopes, nuclear energy and national and international security.
TRIUMF spin-off company secures US$19M investment
ARTMS Inc., TRIUMF spin-off company and global leader in isotope production technology, has announced US$19 million in Series A financing from a consortium led by Deerfield Management Company and Quark Ventures.